Current systemic treatment of hepatocellular carcinoma: A review of the literature
about
Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer StagesRadiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors.Human lung cancer-derived microparticles enhanced angiogenesis and growth of hepatoma cells in rodent lung parenchymaTumor LXR Expression is a Prognostic Marker for Patients with Hepatocellular Carcinoma.Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1.Effects of siRNA-Mediated Knockdown of HDAC1 on the Biological Behavior of Esophageal Carcinoma Cell Lines.Candidate miRNAs and pathogenesis investigation for hepatocellular carcinoma based on bioinformatics analysis.Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma.Phenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways.Clinical and Diagnostic Significance of Homer1 in hepatitis B virus-induced Hepatocellular Carcinoma.High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinoma.The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker.AASLD guidelines for the treatment of hepatocellular carcinomaOrganoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
P2860
Q35843850-96E032E2-B6CF-4F43-BC8B-B4C49CBE29ADQ36084511-47AB1F6F-2644-4A5A-B261-B61225858D9DQ36390438-4C5B3B08-4055-4BC0-85EF-D3B1CC7A0D11Q36404559-943C0AED-530A-48EA-BDDE-C1E27194C800Q36878519-4A6A52DF-28C8-4C36-B7FC-7D7B02229DA1Q38703368-71251B6E-95B3-43BF-92E0-A55E19EFC1B0Q38728160-DC7363F0-7AB2-442C-924F-0F5842654BF8Q38777537-5B7497E6-8496-4C33-A7ED-1EE8A6263745Q40196318-28D22CF4-0C64-455C-825D-B19CF8A1D9B3Q41569014-08239715-E4F6-43B0-A6C4-D37C88CA0243Q47918806-BEE835EC-5E8E-45C1-B287-5048BF3CCB09Q52647682-7AF8C6D6-DCEA-49B6-8025-8C453DDF9EBFQ54988303-B484E1AE-7844-46B9-8F69-749EE8E164F7Q55039660-C8C54123-C3F2-49B3-892D-534B169685B0Q56172239-E06E4B1E-C4BB-4B5A-BCE4-1BFA40ED79D6Q58450461-936E827C-54C2-4B64-95A3-CA7EB4263C65
P2860
Current systemic treatment of hepatocellular carcinoma: A review of the literature
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@ast
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@en
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@nl
type
label
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@ast
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@en
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@nl
prefLabel
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@ast
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@en
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@nl
P2860
P3181
P356
P1476
Current systemic treatment of hepatocellular carcinoma: A review of the literature
@en
P2093
Kai-Wen Chen
P2860
P304
P3181
P356
10.4254/WJH.V7.I10.1412
P407
P577
2015-06-08T00:00:00Z